Goldman Sachs
HURA

Goldman Sachs’s TuHURA Biosciences HURA Stock Holding History

Goldman Sachs’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126K Buy
70,246
+31,153
+80% +$38.2K ﹤0.01% 6177
2025
Q4 		$29.6K Buy
+39,093
New +$74.8K ﹤0.01% 6321
2020
Q4 		– Sell
-11
Closed -$28K – 5753
2020
Q3 		$28K Buy
+11
New +$22.1K ﹤0.01% 5233
2017
Q2 		– Sell
-1
Closed -$46K – 7016
2017
Q1 		$46K Hold
1
– – ﹤0.01% 6311
2016
Q4 		$48K Hold
1
– – ﹤0.01% 6396
2016
Q3 		$109K Buy
+1
New +$124K ﹤0.01% 6191

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Goldman Sachs's HURA Position: Q1 2026 in Review

Goldman Sachs increased its TuHURA Biosciences (HURA) stake by 80% in Q1 2026, buying an estimated $38.2K and bringing the position to 70,246 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #6177.

Goldman Sachs first reported a position in HURA in Q3 2016 and has held it in 6 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Goldman Sachs held 70,246 shares of TuHURA Biosciences worth $126K as of Q1 2026.
  • Goldman Sachs bought 31,153 TuHURA Biosciences shares in Q1 2026, an estimated $38.2K.
  • TuHURA Biosciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6177 holding.
  • Goldman Sachs first reported a position in TuHURA Biosciences in Q3 2016 and has held it in 6 quarters since.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.